Wyeth is currently trading at Rs. 879.40, up by 10.45 points or 1.20% from its previous closing of Rs. 868.95 on the BSE.

The scrip opened at Rs. 851.05 and has touched a high and low of Rs. 880.00 and Rs. 851.05 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1074.80 on 28-Jul-2011 and a 52 week low of Rs. 775.00 on 25-Feb-2011.

Last one week high and low of the scrip stood at Rs. 880.00 and Rs. 825.55 respectively. The current market cap of the company is Rs. 1953.93 crore.

The promoters holding in the company stood at 51.12% while Institutions and Non-Institutions held 18.18% and 30.71% respectively. 

Wyeth has claimed $960 million from Sun Pharmaceutical Industries for alleged patent violation in launching a generic version of acid reflux drug Protonix in the United States. The original patent relating to Protonix, known chemically as pantoprazole sodium, is held by Swiss drugmaker Nycomed and was licensed to Wyeth, which is now owned by Pfizer.

In this regard, Nycomed, owned by Japan's Takeda Pharmaceutical Co. and Wyeth have filed the lawsuit in the US District Court in New Jersey against Sun Pharmaceutical and Teva Pharmaceutical Industries.

Sun launched its generic version of Protonix tablets in January 2008 after Teva Pharmaceutical Industries and its US subsidiary began selling the drug in December 2007.

The pharmaceuticals business of the Wyeth comprises bulk drugs and formulations, such as oral contraceptives, hormone replacement therapy, antibiotics, vaccines, steroids and other prescription medicines. The company also manufactures OTC pharmaceuticals, cosmetics, toiletries and other allied consumer products.

Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×